Key Financial Data Of Reporting Company

COSMOS Pharmaceutical Corporation - Filing #7341374

Concept 2023-06-01 to
2024-02-29
As at
2024-02-29
2023-12-01 to
2024-02-29
As at
2023-05-31
2022-06-01 to
2023-05-31
As at
2023-02-28
2022-12-01 to
2023-02-28
2022-06-01 to
2023-02-28
Key financial data of reporting company
Business results of reporting company
Net sales
715,311,000,000 JPY
827,697,000,000 JPY
606,302,000,000 JPY
Ordinary profit (loss)
25,914,000,000 JPY
33,086,000,000 JPY
24,393,000,000 JPY
Net assets
224,281,000,000 JPY
211,072,000,000 JPY
203,530,000,000 JPY
Total assets
430,241,000,000 JPY
420,967,000,000 JPY
376,930,000,000 JPY
Basic earnings (loss) per share
438.14
145.61
600.96
125.88
411.22
Diluted earnings per share
Equity-to-asset ratio
0.521 xbrli:pure
0.501 xbrli:pure
0.540 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.